These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 29693461)
1. An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Goel R; Hong JS; Findling RL; Ji NY Int Rev Psychiatry; 2018 Feb; 30(1):78-95. PubMed ID: 29693461 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Stepanova E; Dowling S; Phelps M; Findling RL Dialogues Clin Neurosci; 2017 Dec; 19(4):395-402. PubMed ID: 29398934 [TBL] [Abstract][Full Text] [Related]
3. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Ji N; Findling RL Curr Opin Psychiatry; 2015 Mar; 28(2):91-101. PubMed ID: 25602248 [TBL] [Abstract][Full Text] [Related]
4. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present. Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522 [TBL] [Abstract][Full Text] [Related]
5. Psychopharmacological interventions in autism spectrum disorder. Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879 [TBL] [Abstract][Full Text] [Related]
6. Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions. Salloum-Asfar S; Zawia N; Abdulla SA Pharmacol Ther; 2024 Jan; 253():108564. PubMed ID: 38008401 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Lamy M; Erickson CA Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163 [TBL] [Abstract][Full Text] [Related]
8. An Introduction to the Psychopharmacology of Children and Adolescents With Autism Spectrum Disorder. Earle JF J Child Adolesc Psychiatr Nurs; 2016 May; 29(2):62-71. PubMed ID: 27279529 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237 [TBL] [Abstract][Full Text] [Related]
11. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders. Canitano R Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists. Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224 [TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents. Lamy M; Pedapati EV; Dominick KL; Wink LK; Erickson CA Paediatr Drugs; 2020 Oct; 22(5):473-483. PubMed ID: 32686015 [TBL] [Abstract][Full Text] [Related]
14. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study. Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229 [TBL] [Abstract][Full Text] [Related]
15. Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Anagnostou E Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study. Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885 [TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Politte LC; Scahill L; Figueroa J; McCracken JT; King B; McDougle CJ Neuropsychopharmacology; 2018 Jul; 43(8):1772-1778. PubMed ID: 29540864 [TBL] [Abstract][Full Text] [Related]
18. Psychopharmacological interventions in autism spectrum disorder. Politte LC; Henry CA; McDougle CJ Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763 [TBL] [Abstract][Full Text] [Related]
19. The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder. DeFilippis M Psychopharmacol Bull; 2018 Jan; 48(1):40-63. PubMed ID: 29382959 [TBL] [Abstract][Full Text] [Related]
20. Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders. Dhanjal DS; Bhardwaj S; Chopra C; Singh R; Patocka J; Plucar B; Nepovimova E; Valis M; Kuca K Curr Med Chem; 2022; 29(15):2632-2651. PubMed ID: 34823458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]